35
Participants
Start Date
June 10, 2022
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2026
mFOLFOX7+Camrelizumab+Apatinib
"Drug: Leucovorin 200mg/m2 administered IV on Days 1 of a 21 day cycle Drug: Oxaliplatin 85 mg/m2 IV on Days 1 of a 21 day cycle. Drug: Fluorouracil 5-FU continuous infusion: 400mg/m2 on D1 and then 2400mg/m2 for 46h of each 21 day cycle.~Drug: Camrelizumab 200mg infusion on D1 for every 21 days Drug: Apatinib 250mg,po,qd for every 21 days"
RECRUITING
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER